Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Income Before Tax

Profit after all operating and non-operating items but before income tax.

Alamar Biosciences, Inc.NASDAQ: ALMR

Income Before Tax · Q2 FY2026 · quarter ended Jun 2026

Income before tax of -$13.29M in Q2 FY2026

Q2 FY2026 income before tax was -$13.29M.

Context

  • Income before tax amounted to 39.3% of revenue in FY2025.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$13.29M+36.3% QoQ
Last fiscal yearDec 2025
-$29.15M— YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
(29.15M) USD
Year-over-year change
—

Income Before Tax vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 income before tax of -$29.15M is the 2nd highest of the 9 companies compared; the peer median is -$79.1M.
  • Income before tax amounts to 39.3% of revenue for ALMR, versus a peer median of 79.8%.
ALMR Competitors Peer median
Income Before Tax for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TECHBio-Techne CorporationLTM Sep 2026$227.38M +113.9%-10.8%18.5%
ALMRAlamar Biosciences, Inc.FY2025-$29.15M ——39.3%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026-$57.09M +16.9%——
TXG10x Genomics, Inc.LTM Sep 2026-$65.16M +10.9%—10.5%
SEERSeer, Inc.LTM Mar 2026-$70.38M +17.8%—468.0%
LABStandard BioTools Inc.LTM Mar 2026-$87.83M +19.8%—101.8%
QSIQuantum-Si incorporatedLTM Mar 2026-$103.9M -3.2%—5609.9%
PACBPacific Biosciences of California, Inc.LTM Mar 2026-$127.77M +80.6%—79.8%
TWSTTwist Bioscience CorporationLTM Sep 2026-$130.61M -69.7%—28.4%
Peer median (excluding ALMR) -$79.1M+17.4%-10.8%79.8%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.